切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2016, Vol. 05 ›› Issue (05) : 428 -433. doi: 10.3877/cma.j.issn.2095-3224.2016.05.012

所属专题: 文献

综述

结直肠黏液腺癌病理学异质性及与预后的关系
王满香1, 陈琼荣1,()   
  1. 1. 430079 武汉,湖北省肿瘤医院病理科
  • 收稿日期:2016-06-24 出版日期:2016-10-25
  • 通信作者: 陈琼荣
  • 基金资助:
    湖北省自然科学基金资助项目(No.2013CFC022)

The heterogenicity of mucinous colorectal adenocarcinoma and its association with prognosis

Manxiang Wang1, Qiongrong Chen1,()   

  1. 1. Department of Pathology, Hubei Cancer Hospital, Hubei 430079, China
  • Received:2016-06-24 Published:2016-10-25
  • Corresponding author: Qiongrong Chen
  • About author:
    Corresponding author: Chen Qiongrong, Email:
引用本文:

王满香, 陈琼荣. 结直肠黏液腺癌病理学异质性及与预后的关系[J]. 中华结直肠疾病电子杂志, 2016, 05(05): 428-433.

Manxiang Wang, Qiongrong Chen. The heterogenicity of mucinous colorectal adenocarcinoma and its association with prognosis[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2016, 05(05): 428-433.

探讨结直肠黏液腺癌临床病理及分子病理异质性。结合临床病理诊断积累的经验,并复习国内外相关文献,总结结直肠黏液腺癌的临床病理特征、微卫星不稳定性及对预后的影响。结直肠黏液腺癌病理形态特征及微卫星不稳定性状态方面的差异,导致不同的临床生物学行为,对治疗的反应及预后均不相同。结直肠黏液腺癌是一类异质性肿瘤,临床病理和分子病理相结合的精准病理诊断,有利于临床治疗方案的选择和预后分层。

To discuss the heterogenicity of mucinous colorectal adenocarcinoma in respect of clinicopathological and molecular pathology. Review of the relevant literatures combining with our experience of pathological diagnosis, we summarize the morphological characteristics, the status of microsatellite and the effect on the prognosis of patients with mucinous colorectal adenocarcinoma. There are obvious difference among the morphological characteristics and the status of microsatellite in the patients with mucinous colorectal adenocarcinoma, which cause different clinic biologic behaviors, different response to treatment and so different prognosis. Mucinous colorectal adenocarcinoma is a kind of heterogeneous cancer. The precise diagnosis combining with the morphology and molecular pathology drawed by the pathologists, which is benefit to select the therapeutic regimen and helpful for prognostic stratification for the patients.

图1 黏液腺癌的不同分化程度(HE染色,×200)。A和B示黏液湖中漂浮的高分化的腺泡状、条索状异型腺体;C显示中分化异型腺体;D示差分化的单个癌细胞或印戒细胞
图2 高倍镜下PDC分级(HE染色,×400):A示<5个PDC,为1级(G1);B示5~9个PDC,为2级(G2);C示≥10个PDC,为3级(G3)
[1]
Jimi Sei-ichiro,Masayuki Hotokezaka,Takuto Ikeda, et al. Clinicopathological features, postoperative survival and prognostic variables for cancer-related survival in patients with mucinous colorectal carcinoma[J]. Surg Today, 2015, 45(3): 329-334.
[2]
Hamilton SR,Bosman FT,Boffetta P, et al. Carcinoma of the colon and rectum. In: Bosman FT,Carneiro F,Hruban RH,Theise ND, eds. WHO Classification of Tumours of the Digestive System[M]. 4th Edition. Lyon: IARC Press, 2010: 134-146.
[3]
Viganò L,Russolillo N,Ferrero A, et al.Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study[J].Ann Surg,2014, 260(5): 878-884.
[4]
Park JS,Huh JW,Park YA, et al. Prognostic comparison between mucinous and nonmucinous adenocarcinoma in colorectal cancer[J]. Medicine (Baltimore), 2015, 94(15): e658.
[5]
Yoon YS,Kim J,Hong SM,et al. Clinical implications of mucinous components correlated with microsatellite instability in patients with colorectal cancer[J].Colorectal Dis, 2015, 17(8): O161-167.
[6]
Lupinacci RM,Mello ES,Coelho FF, et al. Prognostic implication of mucinous histology in resected colorectal cancer liver metastases[J]. Surgery, 2014, 155(6): 1062-1068.
[7]
Debunne H,Ceelen W. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects[J]. Acta Chir Belg, 2013, 113(6): 385-390.
[8]
Verhulst J,Ferdinande L,Demetter P, et al. Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis[J]. J ClinPathol, 2012, 65(5): 381-388.
[9]
Yamaguchi T,Taniguchi H,Fujita S, et al. Clinicopathological characteristics and prognostic factors of advanced colorectal mucinous adenocarcinoma[J]. Histopathology, 2012, 61(2): 162-169.
[10]
Ooki A,Akagi K,Yatsuoka T, et al. Inverse effect of mucinous component on survival in stage III colorectal cancer[J]. J Surg Oncol, 2014,110(7): 851-857.
[11]
Yeo SA,Chew MH,Koh PK, et al. Inverse effect of mucinous component on survival in stage III colorectal cancer[J]. Tech Coloproctol, 2013, 17(6): 653-661.
[12]
Langner C,Harbaum L,Pollheimer MJ,et al. Mucinous differentiation in colorectal cancer--indicator of poor prognosis[J]? Histopathology, 2012, 60(7): 1060-1072.
[13]
Nervi M,Gambaccini D,Ambrosini CE, et al. Overall prognosis in younger patients with colorectal carcinoma[J].Minerva Chir, 2006, 61(5): 381-384.
[14]
Razenberg LG,van Gestel YR,Lemmens VE,et al. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study[J]. Clin Colorectal Cancer, 2015,14(4): e13-e19.
[15]
Hogan J,Burke JP,Samaha G, et al. Overall survival is improved in mucinous adenocarcinoma of the colon[J]. Int J Colorectal Dis, 2014, 29(5): 563-569.
[16]
Hyngstrom JR,Hu CY,Xing Y, et al. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base[J]. Ann SurgOncol, 2012, 19(9): 2814-2821.
[17]
Gao P,Song YX,Xu YY, et al. Does the prognosis of colorectal mucinous carcinoma depend upon the primary tumour site? Results from two independent databases[J]. Histopathology, 2013, 63(5): 603-615.
[18]
Safaee A,Moghimi-Dehkordi B,Fatemi SR et al. Characteristics of colorectal mucinous adenocarcinoma in Iran[J]. Asian Pac J Cancer Prev, 2010, 11(5): 1373-1375.
[19]
Chen JX,Tang XD,Xiang DB, et al. TNM stages and prognostic features of colorectal mucinous adenocarcinomas: a meta analysis[J]. Asian Pac J Cancer Prev, 2012, 13(7): 3427-3430.
[20]
Kang H,O'Connell JB,Maggard MA, et al. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum[J]. Dis Colon Rectum, 2005, 48(6): 1161-1168.
[21]
Jivapaisarnpong P,Boonthongtho K. Clinicopathological characteristics of mucinous and non- mucinous adenocarcinoma in the colon andrectum in Rajavithi Hospital, Thailand[J]. J Med Assoc Thai, 2011, 94(Suppl 2): S41-S45.
[22]
Zlobec I,Bihl MP,Foerster A, et al. The impact of CpG island methylator phenotype and microsatellite instability on tumour budding in colorectal cancer[J]. Histopathology, 2012, 61(5): 777-787.
[23]
Betge J,Kornprat P,Pollheimer MJ, et al. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer[J]. Ann SurgOncol, 2012, 19(12): 3706-3712.
[24]
Barresi V,ReggianiBonetti L,Ieni A, et al. Histological grading in colorectal cancer: new insights and perspectives[J]. HistolHistopathol, 2015, 30(9): 1059-1067.
[25]
Ueno H,Kajiwara Y,Shimazaki H, et al. New criteria for histologic grading of colorectal cancer[J]. Am J SurgPathol, 2012, 36(2): 193-201.
[26]
Ueno H,Hase K,Hashiguchi Y,et al. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters[J]. Am J Surg Pathol, 2014, 38(2): 197-204.
[27]
Barresi V,Bonetti LR,Ieni A, et al. Histologic grading based on counting poorly differentiated clusters in preoperative biopsy predicts nodal involvement and pTNM stage in colorectal cancer patients[J]. Hum Pathol, 2014, 45(2): 268-275.
[28]
Barresi V,ReggianiBonetti L,Branca G, et al. Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading[J].Virchows Arch, 2012, 461(6): 621-628.
[29]
Ueno H,Shinto E,Kajiwara Y, et al. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer[J]. Br J Cancer, 2014, 111(11): 2082-2090.
[30]
Barresi V,ReggianiBonetti L,Ieni A, et al. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinousadenocarcinoma[J]. Hum Pathol, 2015, 46(11): 1722-1729.
[31]
Moreira L,Balaguer F,Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer[J]. JAMA, 2012, 308(15): 1555-1565.
[32]
Kane MF,Loda M,Gaida GM,et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines[J]. Cancer Res, 1997, 57(5): 808-811.
[33]
Guastadisegni C,Colafranceschi M,Ottini L, et al. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data[J]. Eur J Cancer, 2010, 46(15): 2788-2298.
[34]
Benatti P,Gafà R,Barana D, et al. Microsatellite instability and colorectal cancer prognosis[J]. Clin Cancer Res, 2005, 11(23): 8332-8340.
[35]
Sinicrope FA,Rego RL,Halling KC, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients[J]. Gastroenterology, 2006, 131(3): 729-737.
[36]
Rosty C,Williamson EJ,Clendenning M, et al. Should the grading of colorectal adenocarcinoma include microsatellite instability status[J]? Hum Pathol,2014, 45(10): 2077-2084.
[37]
Barresi V,Bonetti LR. Correlation between microsatellite instability status and grading assessed by the counting of poorly differentiated clusters in colorectal cancer[J]. Hum Pathol, 2015, 46(7): 1063.
[38]
秦云,梁莉萍,郑兴征,等.免疫组织化学法检测结直肠癌四种DNA错配修复蛋白表达缺失对判断肿瘤微卫星状态的价值[J]. 中华病理学杂志, 2015, 44(10): 704-708.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 581-587.
[2] 张思平, 刘伟, 马鹏程. 全膝关节置换术后下肢轻度内翻对线对疗效的影响[J]. 中华关节外科杂志(电子版), 2023, 17(06): 808-817.
[3] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[4] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[9] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[10] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[11] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[12] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[13] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[14] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
[15] 王苏贵, 皇立媛, 姜福金, 吴自余, 张先云, 李强, 严大理. 异质性细胞核核糖蛋白A2B1在前列腺癌中的作用及其靶向中药活性成分筛选研究[J]. 中华临床医师杂志(电子版), 2023, 17(06): 731-736.
阅读次数
全文


摘要